|Articles|October 14, 2019
SEC-MALS Method for Characterizing mRNA Biophysical Attributes
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4